A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: The AFR-15 trial
Saved in:
| Title: | A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: The AFR-15 trial |
|---|---|
| Authors: | Chevallier, Patrice1 patrice.chevallier@chu-nantes.fr, Hunault-Berger, Mathilde2, Larosa, Fabrice3, Dauriac, Charles4, Garand, Richard2, Harousseau, Jean-Luc1 |
| Source: | Leukemia Research. Aug2009, Vol. 33 Issue 8, p1124-1126. 3p. |
| Database: | Academic Search Ultimate |
| ISSN: | 01452126 |
|---|---|
| DOI: | 10.1016/j.leukres.2008.09.030 |
